- News from the prostate cancer community of interest to you. Last updated September 18,2022
Latest Treatment Strategies
The latest prostate cancer news can now be found at https://zerocancer.org/learn/prostate-cancer-news.
Another source of information is a calendar resource for use by the entire prostate cancer community – www.prostatecancercalendar.org.
FDA approvals, new treatments, clinical trials, and studies from around the world can be found at https://zerocancer.org/ustoo/news-you-can-use/
Learn More About Prostate Cancer Treatment Options
Discuss treatment options directly with one of our members. See a call list on our Support Group Counselors/Contact Us tab.
Attend our monthly meetings. See our Calendar of Events. Meetings are from 6:00 PM to 8:00 PM, with a speaker during the first hour. The second hour includes an informal discussion where newly diagnosed men may talk with others and ask questions of men who have been treated.
Stop Random Biopsies with use of MRI
Editor’s Note: The new imaging technology discussed in this article is available locally in the Quad Cities through Metro MRI. If you are facing multiple needle biopsies, discuss with your urologist.
MARINA DEL REY, Calif., Sept. 17, 2014 /PRNewswire/ — Prostate Oncology Specialists announces the launch of the Prostate Vanguard, an awareness campaign to educate men about new imaging technology destined to replace multiple rectal needle biopsies of the prostate. Annually, a million men undergo random needle biopsy of the prostate gland through the rectum. Multi-parametric MRI (MP-MRI) of the prostate gland is non-invasive alternative for diagnosing clinically-significant prostate cancer (CSPC). Men need to be fully informed of their alternatives.
Random needle biopsy is a multibillion dollar industry performed in one-million men annually. Random biopsy is the direct cause of the unfortunate diagnosis of clinically insignificant prostate cancer (CIS-PC) in over 100,000 men annually in the US, leading to rampant overuse of unnecessary radical treatment with surgery or radiation.
Mark Scholz, MD, Medical Director of Prostate Oncology Specialists, Executive Director of the Prostate Cancer Research Institute, and author of Invasion of the Prostate Snatchers, devotes his medical practice exclusively to prostate cancer patients and advocates for raising awareness about the importance of unnecessary biopsies.
Dr. Scholz states, “With new imaging technology, the medical world has the ability to track, measure, and observe small abnormalities in the prostate, which saves men from having to undergo random biopsies which lead to misdiagnosis and over treatment. Click here for more details.
Women play key role in prostate cancer awareness
Women play a valuable role in reminding the men in their lives to get screened for prostate cancer.
According to the Prostate Cancer Foundation, 1 in 6 men are affected by prostate cancer in the U.S. This makes it the most common cancer in America after skin cancer. This year, an estimated 238,000 men will be diagnosed with the disease – many with almost no symptoms – and more than 30,000 men will lose their lives to it.
If detected early, the cure rate for prostate cancer is almost 100 percent. This means that most men who are diagnosed at an early stage will be disease-free after 5 years. These shocking statistics reiterate the importance of getting screened and staying one step ahead of this “silent killer.” Additionally, men should know they are not alone; more than 2.5 million men are living with prostate cancer in America. Fortunately, there are many viable treatment options available.
Watch this informative video with steps you can take to detect prostate cancer early Click here.